The effect of different strains of Helicobacter pylori on platelet aggregation

Canadian Journal of Gastroenterology

Volumn 21, Issue 6, 2007, Pages 367-370

  Corcoran, Paul A ^a   Atherton, John C ^b   Kerrigan, Steve W ^a   Wadstrom, Torkel ^c   Murray, Frank E ^d   Peek, Richard M ^e   Fitzgerald, Desmond J ^a   Cox, Dermot M ^a   Byrne, Michael F ^a,f  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

^d BEAUMONT HOSPITAL   (Ireland)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiovascular disease; H pylori; Platelet aggregation

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; CYTOTOXIC ASSOCIATED GENE A; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CARDIOVASCULAR DISEASE; CELL VACUOLE; CONTROLLED STUDY; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 34547552949     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/490852     Document Type: Article

References (25)

1. Hocker M, Hohenberger P. Helicobacter pylori virulence factors - one part of a big picture. Lancet 2003;362:1231-3.
2. Dundon WG, de Bernard M, Montecucco C. Virulence factors of Helicobacter pylori. Int J Med Microbiol 2001;290:647-58.
3. Kurose I, Granger DN, Evans DJ Jr, et al. Helicobacter pylori-induced microvascular protein leakage in rats: Role of neutrophils, mast cells, and platelets. Gastroenterology 1994;107:70-9.
4. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-4. (Erratum in 1995;311:985).
5. Danesh J, Youngmarr L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study. BMJ 1999;319:1157-62.
6. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000;84:267-71.
7. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71:437-9.
8. Ossei-Gerning N, Moayyedi P, Smith S, et al. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997;35:120-4.
9. Pellicano R, Mazzarello MG, Morelloni S, et al. Acute myocardial infarction and Helicobacter pylori seropositivity. Int J Clin Lab Res 1999;29:141-4.
10. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001;104:25-31.
11. Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxin-associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-4.
12. Koenig W, Rothenbacher D, Hoffmeister A, et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: Lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999;100:2326-31.
13. Stone AF, Mendall MA, Kaski JC, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002;106:1219-23.
14. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000;101:1647-52.
15. Franchini M. Thrombotic thrombocytopenic purpura: Proposal of a new pathogenic mechanism involving Helicobacter pylori infection. Med Hypotheses 2005;65:1128-31.
16. Jackson S, Beck PL, Pineo GF, Poon MC. Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol 2005;78:142-50.
17. Byrne MF, Kerrigan SW, Corcoran PA, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003;124:1846-54.
18. Elizalde JI, Gomez J, Panes J, et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005.
19. Kalia N, Jacob S, Brown NJ, Reed MW, Morton D, Bardhan KD. Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo. Gut 1997;41:748-52.
20. Enders G, Brooks W, von Jan N, Lehn N, Bayerdorffer E, Hatz R. Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: Comparison with membrane proteins from otheT bacteria. Infect Immun 1995;63:2473-7.
21. Hatz RA, Rieder G, Stolte M, et al. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology 1997; 112:1908-19.
22. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004;103:890-6.
23. Miyamoto S, Kawano H, Sakamoto T, et al. Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 2003;89:681-6.
24. McCrae KR. Helicobacter pylori and ITP: Many questions, few answers. Blood 2004;103:752-3.
25. Takahashi T, Yujiri T, Tanizawa Y. Helicobacter pylori and chronic ITP: The discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains. Blood 2004;104:594.